These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25840007)

  • 1. The genetics of neuropsychiatric diseases: looking in and beyond the exome.
    Heinzen EL; Neale BM; Traynelis SF; Allen AS; Goldstein DB
    Annu Rev Neurosci; 2015 Jul; 38():47-68. PubMed ID: 25840007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome versus transcriptome sequencing in identifying coding region variants.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical exome sequencing in neurogenetic and neuropsychiatric disorders.
    Fogel BL; Lee H; Strom SP; Deignan JL; Nelson SF
    Ann N Y Acad Sci; 2016 Feb; 1366(1):49-60. PubMed ID: 26250888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can exome sequencing do for you?
    Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
    J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of next-generation sequencing to the practice of neurology.
    Rexach J; Lee H; Martinez-Agosto JA; Németh AH; Fogel BL
    Lancet Neurol; 2019 May; 18(5):492-503. PubMed ID: 30981321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An automatic and efficient pipeline for disease gene identification through utilizing family-based sequencing data.
    Song D; Li N; Liao L
    Biomed Mater Eng; 2015; 26 Suppl 1():S1797-803. PubMed ID: 26405949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.
    Rotunno M; Barajas R; Clyne M; Hoover E; Simonds NI; Lam TK; Mechanic LE; Goldstein AM; Gillanders EM
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1519-1534. PubMed ID: 32467344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.
    Guerreiro R; Brás J; Hardy J; Singleton A
    Hum Mol Genet; 2014 Sep; 23(R1):R47-53. PubMed ID: 24794858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving views of human genetic variation and its relationship to neurologic and psychiatric disease.
    Geschwind DH
    Handb Clin Neurol; 2018; 147():37-42. PubMed ID: 29325625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease.
    Ku CS; Polychronakos C; Tan EK; Naidoo N; Pawitan Y; Roukos DH; Mort M; Cooper DN
    Mol Psychiatry; 2013 Feb; 18(2):141-53. PubMed ID: 22641181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating contribution of rare non-coding variants to neuropsychiatric disorders.
    Takata A
    Psychiatry Clin Neurosci; 2019 Jan; 73(1):2-10. PubMed ID: 30293238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of next generation sequencing to epilepsy genetics.
    Møller RS; Dahl HA; Helbig I
    Expert Rev Mol Diagn; 2015; 15(12):1531-8. PubMed ID: 26565596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in detecting genetic alterations and their association with human disease.
    Schwartz CE; Chen CF
    J Mol Biol; 2013 Nov; 425(21):3914-8. PubMed ID: 23876707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of linkage analysis, genome-wide association studies, and next-generation sequencing in the identification of disease-causing mutations.
    Londin E; Yadav P; Surrey S; Kricka LJ; Fortina P
    Methods Mol Biol; 2013; 1015():127-46. PubMed ID: 23824853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.
    Li J; Jiang Y; Wang T; Chen H; Xie Q; Shao Q; Ran X; Xia K; Sun ZS; Wu J
    J Med Genet; 2015 Apr; 52(4):275-81. PubMed ID: 25596308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rise and Rise of Exome Sequencing.
    Ku CS; Cooper DN; Patrinos GP
    Public Health Genomics; 2016; 19(6):315-324. PubMed ID: 27898412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.
    Hochstenbach R; Buizer-Voskamp JE; Vorstman JA; Ophoff RA
    Cytogenet Genome Res; 2011; 135(3-4):174-202. PubMed ID: 22056632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of next generation sequencing to molecular diagnosis of inherited diseases.
    Zhang W; Cui H; Wong LJ
    Top Curr Chem; 2014; 336():19-45. PubMed ID: 22576358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery.
    Priya RR; Rajasimha HK; Brooks MJ; Swaroop A
    Methods Mol Biol; 2012; 884():335-51. PubMed ID: 22688718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.